Aarti Industries Q2 FY27 Results: Consolidated Net Profit ₹169 Crore on Total Income of ₹3,676 Crore

Earnings
Specialty chemicals

Blacklitt Research30 October 20263 min read

A chemical plant at night with steam rising from towers and pipework lit by floodlights — Rjendrzejewski, via Wikimedia Commons (CC0). Illustrative image.

Aarti Industries (NSE: AARTIIND) reported consolidated total income of ₹3,676 crore and consolidated net profit of ₹169 crore for the quarter ended 30 Sep 2026, and standalone total income of ₹3,947 crore and standalone net profit of ₹186 crore, it said in a filing on 30 Oct 2026.

Key highlights

Consolidated

Including its subsidiaries

Total income: ₹3,676 crore, up 75.0% YoY and 53.8% QoQ
Net profit and EPS: ₹169 crore, up 59.4% YoY; basic EPS ₹4.65 against ₹2.91 a year earlier
Finance costs: ₹88 crore, down 12.0% YoY and up 6.0% QoQ

Standalone

The company on its own, without its subsidiaries

Total income: ₹3,947 crore, up 89.2% YoY and 75.9% QoQ
Net profit and EPS: ₹186 crore, up 84.2% YoY; basic EPS ₹5.13 against ₹2.77 a year earlier
Exceptional item: A loss of ₹5 crore on conversion of OCDs of Aarti Bharuch Limited

Summary

Consolidated ₹ crore
Particulars	Q2 FY27	Q2 FY26	YoY	Q1 FY27	QoQ
	3,676	2,101	+75.0%	2,390	+53.8%
Revenue from operations	3,668	2,100	+74.7%	2,387	+53.7%
Other income	7	0	n/a	3	+133.3%
	169	106	+59.4%	155	+9.0%
Profit before tax	204	93	+119.4%	180	+13.3%
Finance costs	88	100	-12.0%	83	+6.0%
Depreciation	125	120	+4.2%	124	+0.8%
Tax expense	34	-12	n/a	25	+36.0%
Net profit margin	4.60%	5.05%	-0.45 pp	6.49%	-1.89 pp
EPS, basic (₹)	4.65	2.91	+59.8%	4.27	+8.9%

Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.

Consolidated net profit rose 59.4% YoY, slower than total income, which rose 75.0%. The statement shows the credit but the filing gives no reason for it.

Finance costs fell 12.0% YoY to ₹88 crore, which is 2.4% of total income. Other income is small: ₹7 crore, or 0.2% of total income and 3.4% of profit before tax. Depreciation of ₹125 crore is 3.4% of total income.

The consolidated limited review report notes that the joint venture Augene Chemical Private Limited has not been reviewed by its auditor, and that its share of net loss after tax for the quarter is ₹1.57 crore, furnished by management. The consolidated exceptional item is a gain of ₹2 crore.

Standalone ₹ crore
Particulars	Q2 FY27	Q2 FY26	YoY	Q1 FY27	QoQ
	3,947	2,086	+89.2%	2,244	+75.9%
Revenue from operations	3,942	2,085	+89.1%	2,241	+75.9%
Other income	5	1	+400.0%	3	+66.7%
	186	101	+84.2%	144	+29.2%
Profit before tax	241	88	+173.9%	163	+47.9%
Finance costs	88	99	-11.1%	82	+7.3%
Depreciation	125	120	+4.2%	124	+0.8%
Tax expense	55	-13	n/a	19	+189.5%
Net profit margin	4.71%	4.84%	-0.13 pp	6.42%	-1.70 pp
EPS, basic (₹)	5.13	2.77	+85.2%	3.98	+28.9%

Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.

Standalone net profit rose 84.2% YoY to ₹186 crore, against total income growth of 89.2%. Tax expense of ₹55 crore is 22.8% of profit before tax of ₹241 crore, compared with a credit of ₹13 crore a year earlier.

Standalone finance costs of ₹88 crore are 2.2% of total income, and other income of ₹5 crore is 0.1% of total income. The standalone exceptional item is a loss of ₹5 crore, which the filing describes as non-recurring and relating to a carrying value difference on the conversion of OCDs of Aarti Bharuch Limited into equity shares.

The company has one reportable segment, Specialty Chemicals. Its standalone dividend paid in the half year was ₹36 crore.

Consolidated net worth stood at ₹6,265 crore and standalone net worth at ₹6,285 crore as on 30 Sep 2026. The company says it has retained its long-term issuer and bank facilities credit ratings of AA/Negative from Crisil Limited and India Ratings and Research Private Limited. Listed commercial papers outstanding were ₹600 crore, rated A1+ by both agencies. The filing says the company repaid commercial papers on their due dates.

The reason for the Negative outlook is not stated in the filing.

Inference

The filing confirms the results, the ratings and the commercial paper position. It also reports 14,669 equity shares allotted under the Aarti Industries Limited Performance Stock Option Plan 2022 during the quarter, and the Shanti Intermediates divestment for ₹2 crore in the June 2026 quarter.

Reference: Original filing (PDF)

Sign up to continue reading

Create a free account to read the rest of this article and the analysis that follows.

Disclaimer:

The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

Aarti Industries Q2 FY27 Results: Consolidated Net Profit ₹169 Crore on Total Income of ₹3,676 Crore

Key highlights

Consolidated

Standalone

Summary

Inference

Sign up to continue reading

Disclaimer:

Latest posts

DCM Shriram: ICRA re-affirms ratings and withdraws Commercial Paper item

Advanced Enzyme Technologies closes ₹69.70 crore share buyback

Oil & Natural Gas Corporation: India Ratings affirms debt at IND AAA

The Anup Engineering buys 10% of Arvind GCC, a related-party unit